Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medicine, general & internal (4) 4
cardiovascular disease (3) 3
cardiovascular diseases (3) 3
cerebral infarction (3) 3
children (3) 3
diabetes (3) 3
diabetes mellitus (3) 3
health risk assessment (3) 3
hemoglobin (3) 3
myocardial infarction (3) 3
nasal foreign bodies (3) 3
risk factors (3) 3
stroke (3) 3
unusual odors (3) 3
agonists (2) 2
angina pectoris (2) 2
base-line (2) 2
blood pressure (2) 2
disease control (2) 2
drug dosages (2) 2
female (2) 2
glucagon (2) 2
glucagon-like peptide 1 (2) 2
health risks (2) 2
heart attacks (2) 2
humans (2) 2
hypoglycemia (2) 2
incidence (2) 2
index medicus (2) 2
motivation (2) 2
peptides (2) 2
randomization (2) 2
risk analysis (2) 2
abridged index medicus (1) 1
acute coronary syndrome (1) 1
acute coronary syndromes (1) 1
aged (1) 1
angina (1) 1
angina, unstable - complications (1) 1
angina, unstable - drug therapy (1) 1
blood-glucose control (1) 1
cancer (1) 1
cancer therapies (1) 1
cardiovascular diseases - mortality (1) 1
cardiovascular outcomes (1) 1
cardiovascular safety (1) 1
care and treatment (1) 1
child, preschool (1) 1
cholesterol (1) 1
clinical trials (1) 1
clinical-trials (1) 1
committees (1) 1
complications (1) 1
control methods (1) 1
creatinine (1) 1
cuerpos extraños nasales (1) 1
diabetes mellitus, type 2 - complications (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diagnosis (1) 1
dipeptidyl-peptidase iv inhibitors - adverse effects (1) 1
dipeptidyl-peptidase iv inhibitors - therapeutic use (1) 1
disease (1) 1
double-blind method (1) 1
drug development (1) 1
ecchymosis - etiology (1) 1
efficacy (1) 1
elderly (1) 1
enzymes (1) 1
epidermal growth factor receptors (1) 1
events (1) 1
fda approval (1) 1
foreign bodies - complications (1) 1
foreign bodies - diagnosis (1) 1
foreign-bodies (1) 1
foreign-body reaction - etiology (1) 1
gastrointestinal surgery (1) 1
glycated hemoglobin a - metabolism (1) 1
hypoglycemic agents - adverse effects (1) 1
hypoglycemic agents - therapeutic use (1) 1
incretin (1) 1
inhibitor alogliptin (1) 1
kidney diseases (1) 1
kidneys (1) 1
liraglutide (1) 1
male (1) 1
mellitus (1) 1
microvasculature (1) 1
middle age (1) 1
middle aged (1) 1
myocardial infarction - complications (1) 1
myocardial infarction - drug therapy (1) 1
myocardial-infarction (1) 1
nasal cavity (1) 1
niños (1) 1
nose diseases - etiology (1) 1
odorants (1) 1
olor inusual (1) 1
pancreatitis (1) 1
patient outcomes (1) 1
peptidase (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
by Gerstein, Hertzel C and Colhoun, Helen M and Dagenais, Gilles and Dagenais, Gilles R and Diaz, Rafael and Diaz, Sarahy and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Riesmeyer, Jeffrey S and Riddle, Matthew C and Rydén, Lars and Xavier, Denis and Atisso, Charles Messan and Dyal, Leanne and Hall, Stephanie and Hall, Charles and Rao-Melacini, Purnima and Wong, Gloria and Avezum, Alvaro and Basile, Jan and Chung, Ming-Min and Chung, Namsik and Chung, Jin-Wook and Conget, Ignacio and Cushman, William C and Franek, Edward and Hancu, Nicolae and Hanefeld, Christoph and Hanefeld, Markolf and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Keltai, Katalin and Lanas, Fernando and Leiter, Lawrence A and Lopez-Jaramillo, Patricio and Cardona Munoz, Ernesto German and Pirags, Valdis and Pogosova, Nana and Raubenheimer, Peter J and Shaw, Jonathan E and Sheu, Wayne H-H and Temelkova-Kurktschiev, Theodora and Abella, Mercedes and Alebuena, Andrea and Almagro, Sandra and Amoroso, Eduardo and Anadon, Paula and Andreu, Elizabeth and Aristimuño, Guillermo and Arzadun, Maria and Barbieri, Maria and Barcudi, Raul and Bartolacci, Ines and Bolobanich, Gabriel and Bordonava, Anselmo and Bustamante Labarta, Miguel and Bustos, Betina and Caccavo, Alberto and Camino, Alejandra and Cantero, Maria and Carignano, Maria and Cartasegna, Luis and Cipullo, Marcela and Commendatore, Víctor and Conosciuto, Victoria and Costamagna, Osvaldo and Crespo, Claudia and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dean, Sofia and Dituro, Claudio and Dominguez, Andrea and Farah, Miguel and Fernandez, Alberto and Fernandez, Florencia and Ferrari, Adriana and Flammia, Patricia and Fuentealba, Jose and Gallardo, Karina Beatriz and Garcia, Mar and Garcia, Celso and Garcia, Maria and Garcia Duran, Ruben and Garrido, Marcelo and Gavicola, Rodolfo and Gerbaudo, Claudio and Gilli, Graciela and Giotto, Ana Paula and Godoy Bolzán, Pedro and Gomez Vilamajo, Oscar and Guerlloy, Fernando and Guridi, Cristian and Gutierrez Garrido, Narcisa and Hasbani, Eduardo and Hermida, Sonia and Hominal, Miguel and Hrabar, Adrian and ... and REWIND Investigators
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk... 
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
by Gerstein, Hertzel C and Colhoun, Helen M and Dagenais, Gilles and Dagenais, Gilles R and Diaz, Rafael and Diaz, Sarahy and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Botros, Fady T and Riddle, Matthew C and Rydén, Lars and Xavier, Denis and Atisso, Charles Messan and Dyal, Leanne and Hall, Stephanie and Hall, Charles and Rao-Melacini, Purnima and Wong, Gloria and Avezum, Alvaro and Basile, Jan and Chung, Ming-Min and Chung, Namsik and Chung, Jin-Wook and Conget, Ignacio and Cushman, William C and Franek, Edward and Hancu, Nicolae and Hanefeld, Christoph and Hanefeld, Markolf and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Keltai, Katalin and Lanas, Fernando and Leiter, Lawrence A and Lopez-Jaramillo, Patricio and Cardona Munoz, Ernesto German and Pirags, Valdis and Pogosova, Nana and Raubenheimer, Peter J and Shaw, Jonathan E and Sheu, Wayne H-H and Temelkova-Kurktschiev, Theodora and Abella, Mercedes and Alebuena, Andrea and Almagro, Sandra and Amoroso, Eduardo and Anadon, Paula and Andreu, Elizabeth and Aristimuño, Guillermo and Arzadun, Maria and Barbieri, Maria and Barcudi, Raul and Bartolacci, Ines and Bolobanich, Gabriel and Bordonava, Anselmo and Bustamante Labarta, Miguel and Bustos, Betina and Caccavo, Alberto and Camino, Alejandra and Cantero, Maria and Carignano, Maria and Cartasegna, Luis and Cipullo, Marcela and Commendatore, Víctor and Conosciuto, Victoria and Costamagna, Osvaldo and Crespo, Claudia and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dean, Sofia and Dituro, Claudio and Dominguez, Andrea and Farah, Miguel and Fernandez, Alberto and Fernandez, Florencia and Ferrari, Adriana and Flammia, Patricia and Fuentealba, Jose and Gallardo, Karina Beatriz and Garcia, Mar and Garcia, Celso and Garcia, Maria and Garcia Duran, Ruben and Garrido, Marcelo and Gavicola, Rodolfo and Gerbaudo, Claudio and Gilli, Graciela and Giotto, Ana Paula and Godoy Bolzán, Pedro and Gomez Vilamajo, Oscar and Guerlloy, Fernando and Guridi, Cristian and Gutierrez Garrido, Narcisa and Hasbani, Eduardo and Hermida, Sonia and Hominal, Miguel and Hrabar, Adrian and ... and REWIND Investigators
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the... 
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text El caso de una niña maloliente
by Cuestas, Eduardo and Busso, Raul and Barcudi, Silvina and Tapia, Natalia
Medicina, ISSN 0025-7680, 2005, Volume 65, Issue 4, pp. 341 - 344
Nasal foreign bodies | Children | Unusual odors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text El caso de una niña maloliente A case of a child with bad odor
by Eduardo Cuestas and Raúl Busso and Silvina Barcudi and Natalia Tapia
Medicina (Buenos Aires), ISSN 0025-7680, 08/2005, Volume 65, Issue 4, pp. 341 - 344
El olor emitido por un paciente puede ser uno de los signos guía para el diagnóstico en algunas enfermedades. Ciertas condiciones producen olores... 
nasal foreign bodies | children | cuerpos extraños nasales | niños | olor inusual | unusual odors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A case of a child with bad odor
by Cuestas, E and Busso, R and Barcudi, S and Tapia, N
MEDICINA-BUENOS AIRES, ISSN 0025-7680, 2005, Volume 65, Issue 4, pp. 341 - 344
A case of a child with bad odor, The odor emitted by a patient may be one of the first major clues leading to an early diagnosis. Certain conditions produce a... 
nasal foreign bodies | FOREIGN-BODIES | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | children | unusual odors | Nose Diseases - etiology | Humans | Nasal Cavity | Ecchymosis - etiology | Child, Preschool | Female | Foreign Bodies - complications | Foreign Bodies - diagnosis | Foreign-Body Reaction - etiology | Odorants | Smell | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
by White, William B and Cannon, Christopher P and Heller, Simon R and Nissen, Steven E and Bergenstal, Richard M and Bakris, George L and Perez, Alfonso T and Fleck, Penny R and Mehta, Cyrus R and Kupfer, Stuart and Wilson, Craig and Cushman, William C and Zannad, Faiez and EXAMINE Investigators
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CLINICAL-TRIALS | VASCULAR OUTCOMES | RISK | COMPLICATIONS | THERAPIES | CARDIOVASCULAR SAFETY | MELLITUS | BLOOD-GLUCOSE CONTROL | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights